Immunicum och PCI Biotech tillkännager förlängning av sitt forskningssamarbete med att utforska nya behandlingar med cancervaccin
November 30, 2021 02:00 ET | Immunicum AB
Pressmeddelande  Stockholm 30 november, 2021 Immunicum och PCI Biotech tillkännager förlängning av sitt forskningssamarbete med att utforska nya behandlingar med cancervaccin Immunicum AB...
Immunicum and PCI Biotech Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments
November 30, 2021 02:00 ET | Immunicum AB
Press Release Stockholm, Sweden, November 30, 2021 Immunicum and PCI Biotech Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments Immunicum AB (publ;...
Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften Cells
November 22, 2021 02:00 ET | Immunicum AB
Pressmeddelande22 november 2021 Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften CellsImmunicum AB (publ; IMMU.ST), ett biofarmaceutiskt företag fokuserat på svårbehandlade solida...
Immunicum Publishes DCP-001 Mechanism of Action in the Journal Cells
November 22, 2021 02:00 ET | Immunicum AB
Press ReleaseStockholm, Sweden, November 22, 2021Immunicum Publishes DCP-001 Mechanism of Action in the Journal CellsImmunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on hard-to-treat...
Immunicum presenterar nya forskningsdata vid årsmötet för Society for Immunotherapy of Cancer (SITC)
November 09, 2021 08:00 ET | Immunicum AB
PressmeddelandeStockholm, Sverige, 9 november 2021Immunicum presenterar nya forskningsdata vid årsmötet för Society for Immunotherapy of Cancer (SITC)Immunicum AB (publ; IMMU.ST), ett bioteknikföretag...
Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 09, 2021 08:00 ET | Immunicum AB
Press ReleaseStockholm, Sweden, November 9, 2021Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual MeetingImmunicum AB (publ; IMMU.ST), a biopharmaceutical...
Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH)
November 04, 2021 09:02 ET | Immunicum AB
Press Release  November 4, 2021 Immunicum to Present Data Update on Phase II ADVANCE II at Annual American Society of Hematology Meeting (ASH) Immunicum AB (publ; IMMU.ST), a biopharmaceutical...
Immunicum presenterar uppdaterade resultat för Fas II ADVANCE II vid Annual American Society of Hematology Meeting (ASH)
November 04, 2021 09:02 ET | Immunicum AB
Pressmeddelande 4 november 2021 Immunicum presenterar uppdaterade resultat för Fas II ADVANCE II vid Annual American Society of Hematology Meeting (ASH) Immunicum AB (publ; IMMU.ST), ett...
Immunicum Announces Nomination Committee for the 2022 Annual General Meeting
November 03, 2021 03:00 ET | Immunicum AB
Press Release  November 3, 2021 Immunicum Announces Nomination Committee for the 2022 Annual General Meeting Immunicum AB (publ: IMMU.ST) announced today that the members of the Nomination...
Immunicum tillkännager valberedning inför årsstämman 2022
November 03, 2021 03:00 ET | Immunicum AB
Pressmeddelande  03 november 2021 Immunicum tillkännager valberedning inför årsstämman 2022 Immunicum AB (publ: IMMU.ST) meddelade idag att ledamöterna i valberedningen har utsetts i enlighet...